Study Demonstrates Percutaneous Tibial Nerve Stimulation Offers More Cost-Effective OAB Treatment Than Sacral Nerve Stimulation

[at noodls] – NEWS RELEASE STUDY DEMONSTRATES PERCUTANEOUS TIBIAL NERVE STIMULATION OFFERS MORE COST-EFFECTIVE OAB TREATMENT THAN SACRAL NERVE STIMULATION MINNEAPOLIS, MN, December 6, 2012 – Uroplasty, Inc. (NASDAQ:UPI), … more

View todays social media effects on UPI

View the latest stocks trending across Twitter. Click to view dashboard

See who Uroplasty is hiring next, click here to view